Correction

Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors

D. A. Wainwright, A. L. Chang, M. Dey, I. V. Balyasnikova, C. K. Kim, A. Tobias

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume21
Issue number3
DOIs
StatePublished - Feb 1 2015

Fingerprint

Brain Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{b8a8481da66e4898bccac1dbbfefbd45,
title = "Correction: Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors",
author = "Wainwright, {D. A.} and Chang, {A. L.} and M. Dey and Balyasnikova, {I. V.} and Kim, {C. K.} and A. Tobias",
year = "2015",
month = "2",
day = "1",
doi = "10.1158/1078-0432.CCR-14-3211",
language = "English (US)",
volume = "21",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

Correction : Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors. / Wainwright, D. A.; Chang, A. L.; Dey, M.; Balyasnikova, I. V.; Kim, C. K.; Tobias, A.

In: Clinical Cancer Research, Vol. 21, No. 3, 01.02.2015.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Correction

T2 - Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors

AU - Wainwright, D. A.

AU - Chang, A. L.

AU - Dey, M.

AU - Balyasnikova, I. V.

AU - Kim, C. K.

AU - Tobias, A.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84922388511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922388511&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-14-3211

DO - 10.1158/1078-0432.CCR-14-3211

M3 - Comment/debate

VL - 21

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 3

ER -